Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Beam Technology Enables Less Harmful, More Accurate, and Cost-Effective Radiotherapy

By HospiMedica International staff writers
Posted on 21 Apr 2014
Newly developed technology will enable more effective, less harmful, and drastically less costly radiotherapy and radiosurgery treatment using low-energy X-ray tubes instead of high-energy sources typically used today. More...


Convergent R.N.R., Ltd. (CRnR; Tirat Carmel, Israel) has completed a very effective and promising proof-of-concept session of the Mercy Beam technology.

The Mercy Beam introduces an advanced lens that gathers most of the X-rays emanating divergently out of any traditional X-ray tube (currently used for X-ray imaging) and converges it towards the tumor site. The lens simultaneously removes low-energy photons that would be absorbed by the patient’s skin. The convergence increases the therapeutic dose delivered at the tumor target, while the organs in the vicinity of the tumor receive a very low dose or no dose at all. The converging technology enables the use of photon-energy X-rays 100 times lower than those used by current systems that are based on linear accelerators (LINACs). This technology, because of its low energy requirement, enables a small, light and inexpensive solution in which the cancer is treated accurately with a concentrated radiation at a fraction of the cost of all other methods.

“Today’s radiation treatment and surgery uses very high energy X-ray radiation that not only penetrates the body to reach the tumor, but also scatters towards the surrounding environment including healthy tissue, causing unwanted damage,” said Zeev Harel, CEO of CRnR. “To deal with such high energy X-rays, the protocol requires the machine installation inside a room of several feet of concrete walls, and heavy lead doors, which make those solutions even more expensive. Mercy Beam would revolutionize cancer treatment as we know it today, allowing many patients to receive a merciful, efficient and affordable treatment. The use of low energy X-rays will enable operating the system in standard X-ray rooms [no need for ‘special bunkers’] and in the future even in vans/lorries/trailers that may travel to remote areas. The technology is targeted for treating many types of cancerous tumors with an emphasis on treating of small children.”

Convergent R.N.R. (CRnR) is a medical start-up company developing a new X-ray focusing technology called MercyBeam to perform cancer radiotherapy and radiosurgery. CRnR developed and patented the said break-through technology utilizing a standard imaging X-ray source to form a converging beam into a volume of treatment instead of the conventional diverging or collimated technologies existing today.

Related Links:

Convergent R.N.R.
Mercy Beam



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.